TABLE 6.
Predictors of discharge to SAR following SLKT
| Variables | OR* (95% CI) | P |
|---|---|---|
| Intercept | 0.032 (0.002-0.387) | 0.008 |
| Age (per y) | 1.027 (1.005-1.051) | 0.02 |
| Race Black (vs White) Others (vs White) | 1.20 (0.59-2.41)1.11 (0.48-2.48) | 0.610.81 |
| Female (vs male) | 1.24 (0.80-1.90) | 0.34 |
| EtiologyAlcohol (vs others)Hepatitis C (vs others)NASH/crypto (vs others) | 1.27 (0.69-2.36)1.43 (0.77-2.68)1.72 (0.87-3.39) | 0.450.260.12 |
| SKLT statusFloor (vs ambulatory)ICU (vs ambulatory) | 2.38 (0.97-5.90)5.05 (1.95-13.57) | 0.060.001 |
| Era | ||
| Era 2 2008–2012 (vs <2008–Era 1) | 1.22 (0.69-2.17) | 0.49 |
| Era 3 >2012 (vs ≤2008) | 1.95 (1.11-3.43) | 0.02 |
| Pre-SLKT dialysis (ref = No) | 2.45 (1.49-4.09) | <0.001 |
| BMI (Ref: <18.5 mg/m2–underweight) 18.5–25 kg/m2 26–29 kg/m2 ≥30 kg/m2 | 1.09 (0.22-6.03)1.06 (0.22-5.86)1.02 (0.21-5.71) | 0.920.940.98 |
| Hypertension (ref = No) | 0.81 (0.51-1.30) | 0.39 |
| Diabetes (ref = No) | 1.29 (0.78-2.13) | 0.33 |
| Induction (ref = No) | 1.38 (0.65-3.00) | 0.40 |
| Cyclosporine (vs Tarco) | 0.90 (0.29-2.60) | 0.84 |
| MELD-NA at SLKT | 1.00 (0.97-1.03) | 0.99 |
| Donor age | 0.990 (0.976-1.004) | 0.16 |
| CIT (per min) | 1.001 (0.999-1.002) | 0.23 |
| WIT (per min) | 1.004 (0.997-1.011) | 0.19 |
| KDGF (ref = No) | 2.28 (1.24-4.27) | 0.009 |
BMI, body mass index; CI, confidence intervals; CIT, cold ischemia time; ICU, intensive care unit; KDGF, kidney delayed graft function; MELD-Na, model for end stage liver disease-sodium; NASH, nonalcoholic steatohepatitis; OR, odds ratio; SAR, subacute rehabilitation facility; SLKT, simultaneous liver-kidney transplant; WIT, warm ischemia time.